141 related articles for article (PubMed ID: 3904640)
1. The value of CEA assay in tissue, serum and urine in patients with transitional cell carcinoma of the bladder.
Alampi G; Ronchi E; Galassi A; Soli M; Botteghi B; Bercovich E
Arch Anat Cytol Pathol; 1985; 33(4):193-6. PubMed ID: 3904640
[No Abstract] [Full Text] [Related]
2. [Carcinoembryonic antigen (CEA) in carcinoma of the upper urinary tract and bladder. Immunohistochemical study].
Lanzafame S; Puzzo L; Di Naso C; Di Marco G; Ranno S; Minardi G
Pathologica; 1986; 78(1056):451-8. PubMed ID: 3302887
[No Abstract] [Full Text] [Related]
3. Determination of carcinoembryonic antigen in tissue, serum and urine in patients with transitional cell carcinoma of the urinary bladder.
Jakse G; Rauschmeier H; Rosmanith P; Hofstädter F
Urol Int; 1983; 38(3):121-5. PubMed ID: 6868210
[TBL] [Abstract][Full Text] [Related]
4. [Immunohistochemical localization of epithelial membrane antigen, carcinoembryonic antigen and secretory component in urinary bladder cancer].
Takashi M; Murase T; Mitsuya H; Koshikawa T; Nagura H; Haimoto H
Hinyokika Kiyo; 1986 Apr; 32(4):541-52. PubMed ID: 2426931
[TBL] [Abstract][Full Text] [Related]
5. [Immunohistochemical demonstration of carcinoembryonic antigen (CEA) and ABO (H) blood group antigens on tissue sections of urinary bladder tumors].
Fujioka T; Tanji S; Koike H; Kubo T; Ohhori T
Hinyokika Kiyo; 1985 Oct; 31(10):1709-16. PubMed ID: 3911765
[TBL] [Abstract][Full Text] [Related]
6. [Biologic significance and clinical value of carcinoembryonic antigen in tissues in transitional cell carcinoma of the urinary tract].
Yang SC
Zhonghua Wai Ke Za Zhi; 1989 Apr; 27(4):228-30, 254. PubMed ID: 2805992
[TBL] [Abstract][Full Text] [Related]
7. [Immunologic indices of patients with transitional cell carcinoma of the urinary bladder].
Bkhatta AD; Makhlin NV
Urol Nefrol (Mosk); 1984; (2):67-70. PubMed ID: 6372193
[No Abstract] [Full Text] [Related]
8. [A case of transitional cell carcinoma of the urinary bladder with high serum level of CEA and CA19-9].
Inai H; Shimazui T; Yamamoto T; Yamauchi A; Uchida K; Takeshima H; Akaza H
Hinyokika Kiyo; 2001 Aug; 47(8):583-6. PubMed ID: 11579601
[TBL] [Abstract][Full Text] [Related]
9. Immunohistochemical demonstration of carcinoembryonic antigen (CEA) and its correlation with grading and staging on tissue sections of urinary bladder carcinomas.
Jautzke G; Altenaehr E
Cancer; 1982 Nov; 50(10):2052-6. PubMed ID: 6751517
[TBL] [Abstract][Full Text] [Related]
10. Carcinoembryonic antigen in cytological specimens of urothelial carcinoma.
Holmberg V; Wahren B; Esposti PL
Cytometry; 1984 Jul; 5(4):437-41. PubMed ID: 6380996
[TBL] [Abstract][Full Text] [Related]
11. [Usefulness of carcinoembryonic antigen in transitional cell carcinoma of the bladder].
Moreno Sierra J; Ortega MD; Blanco Jimenez E; Maestro de las Casas ML; Delgado Marti JA; Hermida Gutierrez J; Salinas Casado J; Esteban Fuertes M; Resel Estévez L
Arch Esp Urol; 1994; 47(1):39-42. PubMed ID: 8192496
[TBL] [Abstract][Full Text] [Related]
12. [Urine examination for tumor cells using quantitative immunocytochemistry. Antibodies to a CEA-like antigen].
Sautner D; Saeger W
Fortschr Med; 1995 May; 113(14):207-9. PubMed ID: 7607589
[TBL] [Abstract][Full Text] [Related]
13. Squamous and glandular differentiation in urothelial bladder carcinomas. Histopathology, histochemistry and immunohistochemical expression of carcinoembryonic antigen.
López-Beltrán A; Martín J; García J; Toro M
Histol Histopathol; 1988 Jan; 3(1):63-8. PubMed ID: 2980209
[TBL] [Abstract][Full Text] [Related]
14. [Blood and urinary values of CEA and CA 19-9 in patients with bladder carcinoma].
Cicigoi A; Rocca Rossetti S; Piantino P; Cerchier A
Minerva Med; 1986 Nov; 77(42-43):1983-7. PubMed ID: 3464851
[TBL] [Abstract][Full Text] [Related]
15. Association of ABO (H) antigen negative transitional cell tumours with abnormal mucosal biopsies in superficial bladder cancer.
Das G
Arch Ital Urol Nefrol Androl; 1988 Sep; 60(3):295-9. PubMed ID: 2975863
[No Abstract] [Full Text] [Related]
16. CA19.9 and CEA in transitional cell carcinoma of the bladder: serological and immunohistochemical findings.
Hegele A; Mecklenburg V; Varga Z; Olbert P; Hofmann R; Barth P
Anticancer Res; 2010 Dec; 30(12):5195-200. PubMed ID: 21187512
[TBL] [Abstract][Full Text] [Related]
17. ABO (H) blood group antigens and carcinoembryonic antigens as indicators of malignant potential in patients with transitional cell carcinoma of the bladder.
Nakatsu H; Kobayashi I; Onishi Y; Igawa M; Ito H; Tahara E; Nihira H
J Urol; 1984 Feb; 131(2):252-7. PubMed ID: 6366250
[TBL] [Abstract][Full Text] [Related]
18. [Immunolabelling of urothelial bladder tumors. Value of 2 monoclonal antibodies and perspective in cytology].
Pluot M; Bahroum K; Joundi A; Ducrot P; Diebold MD
Arch Anat Cytol Pathol; 1988; 36(3):69-74. PubMed ID: 2462408
[No Abstract] [Full Text] [Related]
19. [Clinicopathological study of urinary bladder tumors. Clinical evaluation of immunohistochemistry in urine cytology].
Nagata Y; Kinoshita H; Kawamura N; Sasadaira S
Hinyokika Kiyo; 1985 Nov; 31(11):1931-7. PubMed ID: 4091136
[TBL] [Abstract][Full Text] [Related]
20. [Isoantigens ABH in bladder tumors as an indicator of malignant potential. Criteria for the loss of BGA based on the staining pattern by the PAP method and its correlation with CEA and fibronectin].
Nasu Y
Nihon Hinyokika Gakkai Zasshi; 1986 Jun; 77(6):977-87. PubMed ID: 3534405
[No Abstract] [Full Text] [Related]
[Next] [New Search]
